356 related articles for article (PubMed ID: 24108159)
1. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.
Arnheim-Dahlström L; Pasternak B; Svanström H; Sparén P; Hviid A
BMJ; 2013 Oct; 347():f5906. PubMed ID: 24108159
[TBL] [Abstract][Full Text] [Related]
2. Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism.
Frisch M; Besson A; Clemmensen KKB; Valentiner-Branth P; Mølbak K; Hviid A
Int J Epidemiol; 2018 Apr; 47(2):634-641. PubMed ID: 29425361
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.
Hviid A; Svanström H; Scheller NM; Grönlund O; Pasternak B; Arnheim-Dahlström L
J Intern Med; 2018 Feb; 283(2):154-165. PubMed ID: 29044769
[TBL] [Abstract][Full Text] [Related]
4. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Scheller NM; Svanström H; Pasternak B; Arnheim-Dahlström L; Sundström K; Fink K; Hviid A
JAMA; 2015 Jan; 313(1):54-61. PubMed ID: 25562266
[TBL] [Abstract][Full Text] [Related]
5. Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study.
Grönlund O; Herweijer E; Sundström K; Arnheim-Dahlström L
J Intern Med; 2016 Dec; 280(6):618-626. PubMed ID: 27478093
[TBL] [Abstract][Full Text] [Related]
6. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
Yoon D; Lee JH; Lee H; Shin JY
BMJ; 2021 Jan; 372():m4931. PubMed ID: 33514507
[TBL] [Abstract][Full Text] [Related]
7. Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.
Lamb F; Herweijer E; Ploner A; Uhnoo I; Sundström K; Sparén P; Arnheim-Dahlström L
BMJ Open; 2017 Jun; 7(6):e015021. PubMed ID: 28600369
[TBL] [Abstract][Full Text] [Related]
8. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.
Slade BA; Leidel L; Vellozzi C; Woo EJ; Hua W; Sutherland A; Izurieta HS; Ball R; Miller N; Braun MM; Markowitz LE; Iskander J
JAMA; 2009 Aug; 302(7):750-7. PubMed ID: 19690307
[TBL] [Abstract][Full Text] [Related]
9. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
Orumaa M; Kjaer SK; Dehlendorff C; Munk C; Olsen AO; Hansen BT; Campbell S; Nygård M
Vaccine; 2020 Feb; 38(6):1345-1351. PubMed ID: 31917039
[TBL] [Abstract][Full Text] [Related]
10. Safety of the quadrivalent human papillomavirus vaccine.
Brotherton JM
BMJ; 2013 Oct; 347():f5631. PubMed ID: 24108153
[No Abstract] [Full Text] [Related]
11. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
[TBL] [Abstract][Full Text] [Related]
12. No association of HPV vaccination with serious adverse events.
Caskey R
J Pediatr; 2014 May; 164(5):1240. PubMed ID: 24742654
[No Abstract] [Full Text] [Related]
13. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
Grimaldi-Bensouda L; Guillemot D; Godeau B; Bénichou J; Lebrun-Frenay C; Papeix C; Labauge P; Berquin P; Penfornis A; Benhamou PY; Nicolino M; Simon A; Viallard JF; Costedoat-Chalumeau N; Courcoux MF; Pondarré C; Hilliquin P; Chatelus E; Foltz V; Guillaume S; Rossignol M; Abenhaim L;
J Intern Med; 2014 Apr; 275(4):398-408. PubMed ID: 24206418
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events.
Callréus T; Svanström H; Nielsen NM; Poulsen S; Valentiner-Branth P; Hviid A
Vaccine; 2009 May; 27(22):2954-8. PubMed ID: 19428906
[TBL] [Abstract][Full Text] [Related]
16. The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
Skufca J; Ollgren J; Artama M; Ruokokoski E; Nohynek H; Palmu AA
Vaccine; 2018 Sep; 36(39):5926-5933. PubMed ID: 30115524
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus.
McClymont E; Lee M; Raboud J; Coutlée F; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Harris M; Cohen J; Yudin MH; Wobeser W; Money D;
Clin Infect Dis; 2019 Feb; 68(5):788-794. PubMed ID: 29985988
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
[TBL] [Abstract][Full Text] [Related]
19. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis.
Hviid A; Thorsen NM; Valentiner-Branth P; Frisch M; Mølbak K
BMJ; 2020 Sep; 370():m2930. PubMed ID: 32878745
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.
Dehlendorff C; Sparén P; Baldur-Felskov B; Herweijer E; Arnheim-Dahlström L; Ploner A; Uhnoo I; Kjaer SK
Vaccine; 2018 Oct; 36(43):6373-6378. PubMed ID: 30249423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
